Skip to main content
VCbacked
Log inGet Started

Adcentrx Therapeutics

San Diego, United States

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

$51.0M raised
Apr 2023
Series A
BiotechnologyPharmaceutical

Top Investors

F-Prime CapitalPartners InvestmentEight Roads VenturesC-Bridge CapitalQuan Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Adcentrx Therapeutics

How much funding has Adcentrx Therapeutics raised?
Adcentrx Therapeutics has raised $51.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Who are Adcentrx Therapeutics's investors?
Adcentrx Therapeutics's investors include F-Prime Capital, Partners Investment, Eight Roads Ventures, C-Bridge Capital, Quan Capital.
Where is Adcentrx Therapeutics headquartered?
Adcentrx Therapeutics is headquartered in San Diego, United States.
What does Adcentrx Therapeutics do?
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
What stage is Adcentrx Therapeutics at?
Adcentrx Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Adcentrx Therapeutics — Funding & Investors." VCBacked, April 24, 2023, https://www.vcbacked.co/company/adcentrx-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Adcentrx Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/adcentrx-therapeutics
Wikipedia (cite web)
{{cite web |title=Adcentrx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adcentrx-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong